Functional Proteomics Defines the Molecular Switch Underlying FGF Receptor Trafficking and Cellular Outputs

Molecular Cell

Volumn 51, Issue 6, 2013, Pages 707-722

  Francavilla, Chiara ^a   Rigbolt, KristofferT G ^b   Emdal, KristinaB ^a   Carraro, Gianni ^c   Vernet, Erik ^a   Bekker Jensen, DorteB ^a   Streicher, Werner ^a   Wikström, Mats ^a   Sundström, Michael ^a   Bellusci, Saverio ^c   Cavallaro, Ugo ^d   Blagoev, Blagoy ^b   Olsen, JesperV ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2B; KERATINOCYTE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL FATE; CELL MIGRATION; CELL PROLIFERATION; EXPLANT; FUNCTIONAL PROTEOMICS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL MOVEMENT; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; LIGANDS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEOLYSIS; PROTEOMICS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; TYROSINE;

EID: 84884586861     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.08.002     Document Type: Article

References (48)

1. Bae J.H., Schlessinger J. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases. Mol. Cells 2010, 29:443-448.
2. Belleudi F., Leone L., Nobili V., Raffa S., Francescangeli F., Maggio M., Morrone S., Marchese C., Torrisi M.R. Keratinocyte growth factor receptor ligands target the receptor to different intracellular pathways. Traffic 2007, 8:1854-1872.
3. Bellusci S., Grindley J., Emoto H., Itoh N., Hogan B.L. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 1997, 124:4867-4878.
4. Blagoev B., Ong S.E., Kratchmarova I., Mann M. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 2004, 22:1139-1145.
5. Casaletto J.B., McClatchey A.I. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat. Rev. Cancer 2012, 12:387-400.
6. Caswell P., Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol. 2008, 18:257-263.
7. Cha J.Y., Maddileti S., Mitin N., Harden T.K., Der C.J. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform. J.Biol. Chem. 2009, 284:6227-6240.
8. Chamberlain M.D., Oberg J.C., Furber L.A., Poland S.F., Hawrysh A.D., Knafelc S.M., McBride H.M., Anderson D.H. Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking. Cell. Signal. 2010, 22:1562-1575.
9. Choudhary C., Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 2010, 11:427-439.
10. Cunningham D.L., Sweet S.M., Cooper H.J., Heath J.K. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J.Proteome Res. 2010, 9:2317-2328.
11. Dailey L., Ambrosetti D., Mansukhani A., Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005, 16:233-247.
12. De Donatis A., Comito G., Buricchi F., Vinci M.C., Parenti A., Caselli A., Camici G., Manao G., Ramponi G., Cirri P. Proliferation versus migration in platelet-derived growth factor signaling: the key role of endocytosis. J.Biol. Chem. 2008, 283:19948-19956.
13. Dell'Era P., Mohammadi M., Presta M. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. Mol. Biol. Cell 1999, 10:23-33.
14. Ding V.M., Boersema P.J., Foong L.Y., Preisinger C., Koh G., Natarajan S., Lee D.Y., Boekhorst J., Snel B., Lemeer S., et al. Tyrosine phosphorylation profiling in FGF-2 stimulated human embryonic stem cells. PLoS ONE 2011, 6:e17538.
15. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16:139-149.
16. Francavilla C., Cattaneo P., Berezin V., Bock E., Ami D., de Marco A., Christofori G., Cavallaro U. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J.Cell Biol. 2009, 187:1101-1116.
17. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Aktproto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995, 81:727-736.
18. Furdui C.M., Lew E.D., Schlessinger J., Anderson K.S. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 2006, 21:711-717.
19. Hansen S.M., Køhler L.B., Li S., Kiselyov V., Christensen C., Owczarek S., Bock E., Berezin V. NCAM-derived peptides function as agonists for the fibroblast growth factor receptor. J.Neurochem. 2008, 106:2030-2041.
20. Hart K.C., Robertson S.C., Donoghue D.J. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol. Biol. Cell 2001, 12:931-942.
21. Hsu V.W., Bai M., Li J. Getting active: protein sorting in endocytic recycling. Nat. Rev. Mol. Cell Biol. 2012, 13:323-328.
22. Jékely G., Sung H.H., Luque C.M., Rørth P. Regulators of endocytosis maintain localized receptor tyrosine kinase signaling in guided migration. Dev. Cell 2005, 9:197-207.
23. Joffre C., Barrow R., Ménard L., Calleja V., Hart I.R., Kermorgant S. A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 2011, 13:827-837.
24. Katoh M. Cancer genomics and genetics of FGFR2 (Review). Int. J. Oncol. 2008, 33:233-237.
25. Liu B.A., Engelmann B.W., Jablonowski K., Higginbotham K., Stergachis A.B., Nash P.D. SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun. Signal. 2012, 10:27.
26. Makarenkova H.P., Hoffman M.P., Beenken A., Eliseenkova A.V., Meech R., Tsau C., Patel V.N., Lang R.A., Mohammadi M. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2009, 2:ra55.
27. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 1996, 16:977-989.
28. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
29. Nomura S., Yoshitomi H., Takano S., Shida T., Kobayashi S., Ohtsuka M., Kimura F., Shimizu H., Yoshidome H., Kato A., Miyazaki M. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br. J. Cancer 2008, 99:305-313.
30. Ohuchi H., Hori Y., Yamasaki M., Harada H., Sekine K., Kato S., Itoh N. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 2000, 277:643-649.
31. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Global, invivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
32. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
33. Ong S.H., Hadari Y.R., Gotoh N., Guy G.R., Schlessinger J., Lax I. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc. Natl. Acad. Sci. USA 2001, 98:6074-6079.
34. Parachoniak C.A., Luo Y., Abella J.V., Keen J.H., Park M. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev. Cell 2011, 20:751-763.
35. Park J., Park O.J., Yoon W.J., Kim H.J., Choi K.Y., Cho T.J., Ryoo H.M. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis. J.Cell. Biochem. 2012, 113:457-464.
36. Rigbolt K.T., Blagoev B. Quantitative phosphoproteomics to characterize signaling networks. Semin. Cell Dev. Biol. 2012, 23:863-871.
37. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
38. Salazar L., Kashiwada T., Krejci P., Muchowski P., Donoghue D., Wilcox W.R., Thompson L.M. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. Hum. Mol. Genet. 2009, 18:1951-1961.
39. Schulze W.X., Mann M. A novel proteomic screen for peptide-protein interactions. J.Biol. Chem. 2004, 279:10756-10764.
40. Sharma K., Weber C., Bairlein M., Greff Z., Kéri G., Cox J., Olsen J.V., Daub H. Proteomics strategy for quantitative protein interaction profiling in cell extracts. Nat. Methods 2009, 6:741-744.
41. Sigismund S., Confalonieri S., Ciliberto A., Polo S., Scita G., Di Fiore P.P. Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol. Rev. 2012, 92:273-366.
42. Tenhagen M., van Diest P.J., Ivanova I.A., van der Wall E., van der Groep P. Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets. Endocr. Relat. Cancer 2012, 19:R115-R129.
43. Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P., Tacchetti C., Di Fiore P.P. TTP specifically regulates the internalization of the transferrin receptor. Cell 2005, 123:875-888.
44. Turner N., Grose R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 2010, 10:116-129.
45. Vanhaesebroeck B., Stephens L., Hawkins P. PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol. 2012, 13:195-203.
46. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J.Biol. Chem. 1994, 269:5241-5248.
47. Wesche J., Haglund K., Haugsten E.M. Fibroblast growth factors and their receptors in cancer. Biochem. J. 2011, 437:199-213.
48. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J.Biol. Chem. 2006, 281:15694-15700.